CS
MRK icon

Credit Suisse’s Merck MRK Stock Holding History

Credit Suisse’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,183,000
Closed -$167M – 4064
2021
Q4 		$167M Sell
2,183,000
-129,800
-6% -$10.3M 0.09% 218
2021
Q3 		$174M Buy
2,312,800
+1,388,800
+150% +$106M 0.1% 204
2021
Q2 		$71.3M Sell
924,000
-1,112,788
-55% -$82.8M 0.04% 511
2021
Q1 		$150M Sell
2,036,788
-197,862
-9% -$14.6M 0.08% 281
2020
Q4 		$174M Buy
2,234,650
+228,778
+11% +$17.5M 0.09% 245
2020
Q3 		$159M Buy
2,005,872
+807,379
+67% +$63.2M 0.1% 223
2020
Q2 		$88.4M Buy
1,198,493
+752,779
+169% +$56.7M 0.06% 320
2020
Q1 		$32.7M Sell
445,714
-88,661
-17% -$6.97M 0.03% 597
2019
Q4 		$46.4M Sell
534,375
-303,187
-36% -$24.9M 0.03% 591
2019
Q3 		$67.3M Buy
837,562
+264,096
+46% +$21.2M 0.06% 354
2019
Q2 		$45.9M Sell
573,466
-1,527,669
-73% -$117M 0.04% 477
2019
Q1 		$167M Buy
2,101,135
+670,091
+47% +$50.1M 0.15% 116
2018
Q4 		$104M Buy
1,431,044
+686,021
+92% +$48.4M 0.11% 176
2018
Q3 		$50.4M Buy
745,023
+158,143
+27% +$10.1M 0.05% 422
2018
Q2 		$34M Buy
586,880
+272,480
+87% +$15.4M 0.03% 555
2018
Q1 		$16.3M Sell
314,400
-209,600
-40% -$11.3M 0.02% 970
2017
Q4 		$28.1M Buy
524,000
+209,600
+67% +$11.6M 0.03% 690
2017
Q3 		$19.2M Sell
314,400
-288,200
-48% -$17.5M 0.02% 855
2017
Q2 		$36.9M Sell
602,600
-224,377
-27% -$13.7M 0.04% 520
2017
Q1 		$50.1M Buy
826,977
+638,337
+338% +$38.7M 0.05% 435
2016
Q4 		$10.6M Hold
188,640
– – 0.01% 1175
2016
Q3 		$11.2M Buy
188,640
+31,440
+20% +$1.84M 0.01% 1122
2016
Q2 		$8.64M Sell
157,200
-56,382
-26% -$3M 0.01% 1264
2016
Q1 		$10.8M Buy
213,582
+204,464
+2,242% +$10M 0.01% 1067
2015
Q4 		$460K Buy
+9,118
New +$460K ﹤0.01% 3446
2014
Q3 		– Sell
-27,353
Closed -$1.51M – 4578
2014
Q2 		$1.51M Buy
+27,353
New +$1.49M ﹤0.01% 2948

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Credit Suisse's MRK Position: Q1 2024 in Review

Credit Suisse reduced its Merck (MRK) stake by 3.5% in Q1 2024, selling an estimated $28.1M and leaving 6,287,644 shares worth $830M. The position accounts for 0.79% of the portfolio, ranked #18.

Credit Suisse first reported a position in MRK in Q2 2013 and has held it in 43 quarters since. The position peaked at $853M in Q4 2022. 3,535 funds tracked by Wall St. Rank hold MRK as of Q1 2024.

  • Credit Suisse held 6,287,644 shares of Merck worth $830M as of Q1 2024.
  • Credit Suisse sold 227,868 Merck shares in Q1 2024, an estimated $28.1M.
  • Merck made up 0.79% of Credit Suisse's portfolio in Q1 2024, its #18 holding.
  • Credit Suisse first reported a position in Merck in Q2 2013 and has held it in 43 quarters since.
  • Credit Suisse's Merck position peaked at $853M in Q4 2022.
  • 3,535 funds tracked by Wall St. Rank held Merck as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.